Rat flea transmits:
All of the following are true about measles except?
Vertical transmission of pathogens from parent vector to offspring vector is called:
Intensified malaria control under the national framework for malaria elimination is defined as:
Which of the following is the LEAST important step in the national TB control program?
True statement about Japanese Encephalitis is:
Best strategy for leprosy eradication programme is
All are included in acute flaccid paralysis surveillance, except -
Which is not used in ORS:
Which microorganism is considered the MOST significant agent for use as a weapon in biological terrorism?
Explanation: ***Endemic typhus*** - **Endemic typhus**, also known as **murine typhus**, is transmitted by the **rat flea (Xenopsylla cheopis)**, which carries the bacterium **Rickettsia typhi**. - The flea bites humans after feeding on infected rats, transmitting the bacteria. *Lassa fever* - **Lassa fever** is a **viral hemorrhagic fever** transmitted to humans primarily through contact with food or household items contaminated with urine or feces of **infected multimammate rats**. - It is not transmitted by fleas. *Trachoma* - **Trachoma** is a chronic infectious eye disease caused by the bacterium **Chlamydia trachomatis**. - It is transmitted through direct or indirect contact with eye and nose discharge of infected individuals, often via **flies (Musca sorbens)** that land on the eyes. *Rabies* - **Rabies** is a **viral disease** that is transmitted to humans through the saliva of infected animals, most commonly via a **bite** from an infected mammal such as a **dog, bat, or fox**. - It is not transmitted by fleas.
Explanation: ***Secondary attack rate is 30%*** - The **secondary attack rate** for measles is extremely high, typically around **90%** in susceptible household contacts, making it one of the most contagious infectious diseases. - A rate of 30% would imply a much lower transmissibility than what is characteristically observed for measles. *I.P. = 7-14 days* - The **incubation period (I.P.)** for measles is typically 7-14 days from exposure to the onset of fever. - This is a well-established and accurate timeframe for the disease. *Best age for immunization is 9-12 months* - The **first dose** of the measles-mumps-rubella (MMR) vaccine is generally recommended between **9-12 months** of age in many parts of the world, especially in endemic areas, to provide early protection. - This timing balances the waning of maternal antibodies with the need for effective immunization. *Maximum incidence in 6m-3 year age group* - In areas with lower vaccination coverage, measles incidence is indeed highest in **preschool-aged children**, particularly those between 6 months and 3 years, as maternal antibodies wane and they become more exposed. - This age group is highly susceptible due to their developing immune systems and social interactions.
Explanation: ***Transovarian*** - **Transovarian transmission** refers to the passage of a pathogen from an infected adult female vector directly into her offspring, often via the ova. - This mode of transmission ensures disease persistence in subsequent generations of vectors without requiring re-infection from an external host. *Mechanical transmission* - **Mechanical transmission** involves a pathogen being carried on the exterior of a vector (e.g., on legs or proboscis) from an infected host to a susceptible one, without replication or development within the vector. - The vector serves as a "flying syringe" or a simple carrier, not allowing for biological multiplication or development of the pathogen. *Cyclodevelopmental transmission* - In **cyclodevelopmental transmission**, the pathogen undergoes both developmental changes and multiplication within the vector. - An example is **filarial worms** in mosquitoes, where the parasite develops into the infective stage and also multiplies in the vector. *Propagative transmission* - **Propagative transmission** involves the pathogen multiplying within the vector but not undergoing any significant developmental changes. - A classic example is the **Arbovirus** replication within mosquitoes, where the virus replicates to high titers in the vector's tissues.
Explanation: ***States with API >=1*** - Intensified malaria control under a national elimination framework targets regions with an **Annual Parasite Index (API) of 1 or greater**, indicating a significant burden of malaria requiring focused intervention. - This threshold helps prioritize resources and strategies to areas where malaria transmission is still active and potentially high, moving towards reduction and eventual elimination. *No longer a health problem* - This definition would classify an area as having achieved **malaria elimination**, which is a far more advanced stage than intensified control. - Intensified control is implemented when malaria is still a health problem, albeit one that is being actively managed to reduce its impact. *Zero incidence of malaria* - Zero incidence signifies **complete interruption of local malaria transmission**, meaning no new cases are occurring locally. - While the ultimate goal, intensified control aims to *reduce* incidence significantly, not necessarily achieve zero incidence immediately. *3 consecutive years no local transmission in the state* - This criterion typically defines **malaria elimination**, not intensified control. - Elimination is declared when there has been no local transmission for a sustained period, indicating a successful control program has halted the disease.
Explanation: ***BCG vaccination*** - While BCG vaccination offers some protection against severe forms of TB, particularly in children, it has **limited efficacy** against adult pulmonary TB, which is the primary driver of transmission. - The national TB control program's main focus is on **interrupting transmission** by identifying and effectively treating infectious cases. *Treatment of sputum positive cases* - This is a cornerstone of TB control because **sputum-positive cases** are the primary source of airborne transmission. - Effective treatment rapidly renders patients **non-infectious**, preventing further spread of the disease within the community. *Isolation of sputum positive cases* - **Isolation** of highly infectious individuals helps to prevent the immediate spread of *Mycobacterium tuberculosis* to others in close contact. - This is a crucial **infection control measure**, especially in healthcare settings and within households. *Treatment of contacts* - Treating contacts, especially those with **latent TB infection (LTBI)** or who are at high risk of progression to active disease (e.g., immunocompromised individuals), is vital for preventing the development of new active cases. - This strategy targets the **prevention of future active disease** in individuals already exposed to the bacterium.
Explanation: ***Pigs are amplifier hosts*** - **Pigs** serve as the primary **amplifier hosts** for the Japanese Encephalitis virus, increasing the viral load in the environment and facilitating transmission to mosquitoes. - This amplification is crucial in the **epidemiology** of Japanese Encephalitis, as pigs sustain the transmission cycle between mosquitoes and maintain high viral loads. - This is the **most definitive and unique** characteristic statement about JE epidemiology. *No vaccine for JE* - This statement is incorrect; there are **effective vaccines available** for Japanese Encephalitis, recommended for travelers to endemic areas and high-risk populations. - Examples include inactivated vaccines (Ixiaro) and live-attenuated vaccines (SA 14-14-2, widely used in India's Universal Immunization Programme). *Cross reacts with Dengue virus* - While this statement is technically true, both Japanese Encephalitis virus (JEV) and Dengue virus (DENV) are **flaviviruses** and share common epitopes causing **serological cross-reactivity** in IgM/IgG tests. - However, this cross-reactivity is a **diagnostic challenge** rather than a defining epidemiological feature of JE itself. - This cross-reactivity is a property shared by multiple flaviviruses (including Zika, Yellow Fever, West Nile), making it less specific to JE. *Mortality less than 10%* - This statement is incorrect. The **case fatality rate** for symptomatic Japanese Encephalitis is significant, typically ranging from **20% to 30%**. - Even among survivors, severe neurological or psychiatric sequelae are common, affecting 30-50% of patients.
Explanation: ***Early diagnosis and treatment*** - **Early detection** of leprosy cases and prompt initiation of **multidrug therapy (MDT)** is the cornerstone of leprosy control and eradication programs. - This approach stops transmission by rendering patients non-infectious quickly, preventing further spread of the disease and reducing the incidence of disability. *Mass chemotherapy* - **Mass chemotherapy** involves treating a large population indiscriminately, which is generally not efficient or sustainable for leprosy control. - It could lead to **drug resistance** and unnecessary side effects in individuals who are not infected. *High risk chemotherapy* - **High-risk chemotherapy** typically targets specific populations with known high exposure or vulnerability, which might be a component of control but not the *best* overall strategy for eradication. - It might miss undetected cases outside the defined "high-risk" groups, allowing continued transmission. *Health education* - **Health education** is crucial for increasing awareness, reducing stigma, and promoting early presentation, but by itself, it cannot *control* or *eradicate* the disease. - It is a supportive measure that enhances the effectiveness of medical interventions by encouraging community participation and compliance with treatment.
Explanation: ***Transient weakness*** - **Surveillance for acute flaccid paralysis (AFP)** focuses on persistent flaccid weakness, not temporary or transient weakness. The goal is to identify and investigate cases that could be **poliomyelitis** or other serious neurological conditions causing lasting paralysis. - While transient weakness might be a symptom in some conditions, it is not a criterion for inclusion in standard AFP surveillance, which specifically looks for **acute onset** and progressive or sustained flaccidity. *Age* - **Age** is a crucial component of AFP surveillance, particularly because poliomyelitis primarily affects **children under 15 years old**. Surveillance systems often target this age group to maximize the chances of detecting polio cases. - Data on the age of affected individuals is used to track epidemiological patterns and assess the effectiveness of **vaccination programs**. *No cause* - Cases where **no cause** is immediately apparent are specifically included in AFP surveillance to ensure that all potential cases of **poliomyelitis** are investigated. This is particularly important in regions working towards polio eradication. - Investigating cases with no obvious cause helps to rule out polio and identify other **etiologies of flaccid paralysis**, contributing to a broader understanding of neurological diseases. *Tone* - The assessment of **muscle tone** is fundamental to defining flaccid paralysis. **Reduced or absent muscle tone (flaccidity)** is a defining characteristic of AFP. - **Tone** helps differentiate AFP from other forms of paralysis (e.g., spastic paralysis) and guides the diagnostic workup for conditions like **Guillain-Barré Syndrome** or poliomyelitis.
Explanation: ***Glucose without salt*** - **Oral Rehydration Solution (ORS)** formulations specifically include both **glucose and salts (electrolytes)**, as the sodium-glucose co-transport mechanism is crucial for optimal water and electrolyte absorption in the gut. - Using glucose alone without salts would be far less effective for rehydration and replenishing electrolyte losses during conditions like diarrhea. *Glucose with salt* - This combination is the **fundamental basis** of ORS, as **glucose facilitates sodium absorption** and, by extension, water absorption, into the body. - The presence of both glucose and various salts (like sodium chloride, potassium chloride, and sodium citrate) is essential for the efficacy of ORS in **rehydrating and correcting electrolyte imbalances**. *Na+* - **Sodium (Na+)** is a critical electrolyte included in ORS to replace losses and is vital for maintaining fluid balance and various physiological functions. - The correct balance of sodium, along with glucose, is essential for the **co-transport mechanism** that drives water absorption in the intestines. *All of the options* - This option is incorrect because both **glucose with salt (the combination)** and **Na+** are integral components of a standard ORS formulation. - The specific exclusion stated in the question (glucose without salt) is the feature that is *not* used in ORS.
Explanation: ***Smallpox*** - **Smallpox** is considered a high-priority biological weapon agent due to its **high infectivity**, person-to-person transmission, and high mortality rate. - The discontinuation of global vaccination has led to a population with **minimal immunity**, making it a potent bioweapon. *Influenza* - While influenza viruses are highly transmissible and can cause significant illness, their **mortality rate is generally lower** than agents specifically chosen for biological warfare. - Widespread immunity from natural exposure and annual vaccination campaigns limits its effectiveness as a primary bioweapon. *Ebola* - **Ebola virus** causes severe hemorrhagic fever with a high fatality rate but is typically **less easily transmitted** than agents like smallpox through airborne routes. - Its outbreaks are usually localized, and containment measures are effective in preventing widespread pandemic spread, making it less ideal for mass casualty scenarios compared to smallpox. *Rabies* - **Rabies virus** is transmitted primarily through the bite of an infected animal and is **not easily spread from person to person**. - Its **incubation period is long**, and post-exposure prophylaxis is highly effective, making it an impractical agent for widespread biological terrorism.
Communicable Disease Control Principles
Practice Questions
Vector-Borne Diseases
Practice Questions
Water-Borne Diseases
Practice Questions
Air-Borne Diseases
Practice Questions
Zoonotic Diseases
Practice Questions
Sexually Transmitted Infections
Practice Questions
HIV/AIDS Control Program
Practice Questions
Tuberculosis Control
Practice Questions
Leprosy Elimination
Practice Questions
Emerging and Re-emerging Infections
Practice Questions
Hospital-Acquired Infections
Practice Questions
Integrated Disease Surveillance Project
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free